statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	755
SG - Singapore	127
CN - Cina	66
BR - Brasile	65
IT - Italia	65
RU - Federazione Russa	46
HK - Hong Kong	41
DE - Germania	37
SE - Svezia	34
VN - Vietnam	31
FR - Francia	27
FI - Finlandia	20
IN - India	16
GB - Regno Unito	14
CI - Costa d'Avorio	12
BD - Bangladesh	10
CA - Canada	10
ID - Indonesia	10
PH - Filippine	10
JP - Giappone	7
MX - Messico	7
UA - Ucraina	7
IQ - Iraq	5
NL - Olanda	5
KE - Kenya	4
TR - Turchia	4
AT - Austria	3
CO - Colombia	3
IR - Iran	3
LT - Lituania	3
PT - Portogallo	3
PY - Paraguay	3
UZ - Uzbekistan	3
VE - Venezuela	3
AO - Angola	2
CH - Svizzera	2
EC - Ecuador	2
EG - Egitto	2
ES - Italia	2
MY - Malesia	2
PK - Pakistan	2
PL - Polonia	2
TN - Tunisia	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
BE - Belgio	1
BG - Bulgaria	1
CL - Cile	1
GM - Gambi	1
GT - Guatemala	1
HR - Croazia	1
IE - Irlanda	1
IL - Israele	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
RO - Romania	1
SA - Arabia Saudita	1
SI - Slovenia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UY - Uruguay	1
VC - Saint Vincent e Grenadine	1
Totale	1.499

Nome	#
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis	231
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis	165
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis	160
Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles-New Insights for Structural and Functional Studies	160
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis	154
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis	143
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience	140
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method	109
Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A	107
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity	90
null	62
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	22
Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients	20
Totale	1.563

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	30	0	0	0	0	0	0	0	0	0	10	14	6
2021/2022	78	1	9	4	2	3	8	2	3	8	4	11	23
2022/2023	131	13	20	11	13	18	12	1	14	19	0	3	7
2023/2024	46	3	7	3	3	2	10	1	5	0	2	0	10
2024/2025	294	13	4	13	8	13	21	34	36	18	31	40	63
2025/2026	663	95	36	58	68	90	49	72	30	97	68	0	0
Totale													1.563